Ascenta Therapeutics' Series B Round

Ascenta Therapeutics raised a round of funding on November 08, 2004.

Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio …

Articles about Ascenta Therapeutics' Series B Round: